Colorectal cancer follows a pattern that makes PET CT particularly useful at some moments and largely unnecessary at others. Understanding which moment you are in prevents both unnecessary scans and missed ones.
The pattern is this: colorectal cancer spreads to the liver more predictably than most cancers, and it is one of the few cancers where surgery to remove those liver secondaries can be part of curative treatment. That single fact drives most of what follows.
This guide explains when PET adds real value in colorectal cancer, why it is generally not used for routine initial staging, what a rising CEA means and why it often leads to a PET, the specific problem of assessing the liver and rectum, and the preparation points that matter here more than elsewhere.
Why the liver dominates the discussion
Blood from the bowel drains through the portal vein into the liver before it reaches the rest of the body. That anatomy means colorectal cancer cells commonly lodge in the liver first.
What makes this important rather than simply unfortunate is that liver metastases from colorectal cancer are, in selected patients, surgically removable with intent to cure. That is unusual. In many cancers, spread to the liver changes the goal of treatment entirely. In colorectal cancer, it may not.
So the critical question becomes: if we operate on the liver, will that actually deal with all the disease — or is there something else elsewhere that we have not seen?
An operation on the liver is major surgery. Performing it and then discovering untreated disease elsewhere shortly afterwards helps nobody.
This is where a whole-body PET earns its place: before liver surgery, to check that the liver really is the only site involved.
When PET CT genuinely adds something
Before liver or lung metastasectomy
The main use. Where surgery on metastatic disease is being planned with curative intent, a whole-body survey confirms that the plan addresses all known disease. Finding additional sites changes the plan — which is precisely the point.
Rising CEA with normal or equivocal conventional imaging
Covered in detail below. This is one of the most common reasons a colorectal patient is sent for a PET.
Suspected recurrence
Where symptoms, examination findings or surveillance imaging suggest disease has returned and the extent needs mapping.
Equivocal findings on CT
An indeterminate liver lesion, an uncertain lung nodule, an enlarged node of unclear significance — situations where a functional assessment helps resolve the question.
Assessing response in selected situations
Particularly where treatment is being given to convert unresectable liver disease into something operable, and the team needs to judge whether that has been achieved.
When PET is usually not the right scan
Being clear about this saves money and radiation.
Routine initial staging of colorectal cancer is generally done with CT, not PET. A contrast CT of chest, abdomen and pelvis is the standard staging investigation, and for most patients it answers the question.
Local staging of rectal cancer is done with MRI, not PET. For rectal tumours, what matters is how far the tumour extends through the bowel wall, its relationship to the mesorectal fascia, and involvement of local nodes. That is a question of millimetres and soft tissue planes — MRI territory. PET cannot resolve it, and it is not asked to.
Routine surveillance PET after treatment is generally not recommended in the absence of a specific concern. Follow-up is usually clinical review, CEA monitoring, CT and colonoscopy, with PET reserved for when something needs resolving.
So if your surgeon has ordered a CT and an MRI but not a PET, that is normal practice for early disease, not an omission.
Rising CEA — what it means and what happens next
CEA is a tumour marker measured in blood. It is followed after colorectal cancer treatment because a rise can indicate recurrence before anything is visible on imaging or felt on examination.
The typical sequence when CEA rises:
- The test is repeated, because a single reading can fluctuate for reasons that have nothing to do with cancer.
- Conventional imaging is done — usually a contrast CT — to look for an obvious site.
- If the CT shows nothing, or shows something equivocal, a PET CT is often the next step, because it can find metabolically active disease that has not yet produced a structural change large enough to see.
Two things are worth knowing if you are in this situation.
CEA can rise for benign reasons. Smoking raises it. So do some inflammatory conditions and liver disease. A rise is a signal to investigate, not a diagnosis.
A negative PET after a rising CEA is not necessarily a false alarm — or a false reassurance. Small volumes of disease may be below reliable detection, and some mucinous tumours show limited uptake. Your team will decide whether to repeat imaging after an interval rather than concluding either way. That interval feels uncomfortable, but it is often the right call.
Where PET has limitations in colorectal cancer
Mucinous tumours
Mucinous adenocarcinomas contain a large proportion of mucin, which is not metabolically active. These tumours frequently show lower FDG uptake than their size or behaviour would suggest. A PET can therefore under-represent mucinous disease, and your team reads it with that in mind.
Small peritoneal deposits
Peritoneal spread often takes the form of numerous very small deposits rather than a single mass. Below a certain size, these are not reliably detected by any scan, PET included. Where peritoneal disease is suspected and the extent matters — for instance before cytoreductive surgery — laparoscopy may be used.
Small liver lesions
Very small liver metastases may fall below reliable detection on PET. Contrast-enhanced MRI of the liver is often more sensitive for small lesions, which is why a patient being assessed for liver surgery may reasonably have both.
After chemotherapy
Chemotherapy can suppress FDG uptake in liver lesions temporarily, so a scan performed shortly after treatment may under-represent disease. Timing is planned for this reason.
The bowel itself
Normal bowel shows variable physiological uptake, and it can be considerable. Bowel uptake is a common source of uncertainty and often needs correlation with colonoscopy or a CT appearance rather than being read in isolation.
One useful consequence: incidental focal bowel uptake found on a PET done for another reason sometimes turns out to be a polyp or an early lesion. If your report mentions focal bowel uptake, your doctor may recommend a colonoscopy. That is a reasonable follow-up, not alarmism.
Preparation
Standard FDG preparation applies, with a few points that matter particularly here.
Fasting
Usually around 6 hours. Plain water allowed and encouraged. No tea, coffee, juice, sweets or chewing gum.
Blood sugar
Checked before injection, because circulating glucose competes with the tracer. Diabetic patients should mention it at booking so medication timing can be planned. Do not skip medication on your own initiative.
Bowel preparation
Ask the centre what your protocol requires. It varies, and instructions may differ from what you were given for a colonoscopy or a CT.
Avoid exertion
No strenuous activity for around 24 hours beforehand.
Stay warm and stay still
Standard, but worth repeating: cold activates brown fat, and movement or talking during the 45 to 60 minute uptake period produces muscle uptake.
Tell the centre these things when you book
- The dates of any recent chemotherapy or radiotherapy
- The date of any recent surgery, colonoscopy, biopsy or stent placement
- Whether you have a stoma
- Whether you have any active infection, fever or abdominal collection
- Whether you are diabetic, and what you take
- Your recent CEA results, if the scan was prompted by a rise
If you have a stoma, say so at booking. It does not prevent the scan, but it is relevant to preparation and positioning, and telling the team in advance is more comfortable than explaining on the table.
What to bring
- The prescription, with the clinical indication written on it
- All previous CT and MRI scans — films or CD, not just reports
- Previous PET scans, if any
- CEA results over time, not just the latest one — the trend is what matters
- Colonoscopy and histopathology reports
- Operative notes, if you have had surgery
- A list of current medications
- Insurance or reimbursement papers, if you plan to file a claim
- Photo identification
The CEA trend is worth emphasising. A single value tells the reporting physician far less than a sequence showing the direction and rate of change.
Reading the report
A colorectal PET report describes the primary or operative site, then works through the liver, lungs, peritoneum, lymph nodes and bones — the common sites of spread in this disease.
Liver findings deserve particular attention. If liver surgery is being considered, the number, size and location of lesions relative to the vessels determines what is technically possible. PET and MRI often complement each other here.
SUVmax measures tracer accumulation adjusted for dose and weight. It is not a cancer score — inflammation raises it, and mucinous tumours may show low uptake. It is most meaningful compared against a previous scan.
Bowel uptake, as described above, frequently needs correlation rather than standing alone.
The impression is the reporting physician’s summary and the part your surgeon or oncologist reads first.
Radiation and safety
A PET CT involves ionising radiation from the tracer and the CT component, which is why it is ordered for specific questions rather than routinely. Fluorine-18 has a half-life of under two hours and essentially none remains active by the next day.
Precautions afterwards are simple and temporary: drink water, and keep some distance from pregnant women and young children for the rest of the day.
If you are pregnant, breastfeeding or might be pregnant, raise it before the scan is scheduled.
What decides the cost
Colorectal studies are usually FDG whole body, which is Rs 7,999 all-inclusive — the figure includes the scan, the tracer and the reporting, and nothing is added at the counter. Contrast or additional views are occasionally required by the protocol; send the prescription and we will confirm the complete figure for your exact study in writing.
If your team has also asked for a liver MRI, that is a separate investigation with its own cost — worth clarifying early.
Where liver lesions need characterising, FDG whole body with triple phase is Rs 13,499, on the same all-inclusive basis.
Ask these before you book
- Is the tracer included in the figure you quoted?
- Is contrast included, if my protocol requires it?
- Is reporting included?
- What is the total I will pay at the counter? In writing.
- Will my previous CT and MRI scans be compared?
- Is this the right interval after my last chemotherapy cycle?
- When will the report be ready, and can it be before my surgical or oncology appointment on [date]?
Where Neurad fits
Neurad Diagnostic and Healthcare LLP is a dedicated PET-CT and nuclear medicine centre at B-3, opposite Metro Pillar No. 233, near Paschim Vihar West Metro Station, New Multan Nagar, Paschim Vihar, New Delhi-110056. Monday to Saturday, 8:00 AM to 5:00 PM.
Reported by our own nuclear medicine team, not outsourced.
Your previous CT and MRI scans compared, provided you bring them — which matters especially where liver surgery is being planned.
Triphasic and multiphasic CT available, relevant where liver lesions need characterising alongside the metabolic assessment.
Written preparation instructions specific to your study, sent when you book.
Blood sugar checked before injection as standard, with diabetic patients planned in advance.
Stoma and comfort needs planned in advance if you tell us at booking.
Image-guided FNAC and biopsy available, so where a lesion needs tissue confirmation it can often be arranged without another centre and another journey.
Complimentary pickup and drop within 3 km; beyond that, Rs 50 per km.
The all-inclusive figure in writing before you book.
Frequently asked questions
Do I need a PET CT for colorectal cancer staging?
Usually not for routine initial staging — that is generally done with a contrast CT of chest, abdomen and pelvis, and for rectal cancer with a pelvic MRI as well. PET is used for specific questions such as assessing before metastasectomy or investigating a rising CEA.
Why do I need a PET before liver surgery?
Because liver surgery for colorectal metastases is major surgery undertaken with curative intent. A whole-body survey checks that the liver really is the only site involved, so the operation addresses all known disease rather than part of it.
My CEA is rising but the CT is normal. What happens now?
This is one of the commonest reasons for a PET CT in colorectal cancer. PET can identify metabolically active disease that has not yet produced a structural change visible on CT. If the PET is also negative, your team may repeat imaging after an interval rather than concluding either way.
Can CEA rise without cancer coming back?
Yes. Smoking raises CEA, as do some inflammatory conditions and liver disease. A single raised value is a reason to investigate, not a diagnosis. The trend over several readings is more informative than any one result.
Is PET used for rectal cancer local staging?
No. Local staging of rectal cancer is an MRI question — how far the tumour extends through the wall, its relationship to the mesorectal fascia, local nodes. That level of soft tissue detail is beyond what PET is designed for.
My tumour is mucinous. Is PET reliable?
Mucinous adenocarcinomas often show lower FDG uptake because mucin is not metabolically active. A PET may therefore under-represent the disease, and your team reads it with that in mind alongside CT and MRI.
Can PET detect peritoneal spread?
Larger deposits, yes. Peritoneal disease often consists of many very small deposits that fall below reliable detection on any scan. Where the extent matters, for example before cytoreductive surgery, laparoscopy may be used.
My report mentions bowel uptake. Is that cancer?
Not necessarily — normal bowel shows variable physiological uptake. Focal uptake sometimes turns out to be a polyp or an early lesion, which is why your doctor may recommend a colonoscopy to correlate. That is sensible follow-up rather than cause for alarm.
Should I have routine PET scans after treatment?
Routine surveillance PET in the absence of a specific concern is generally not recommended. Follow-up is usually clinical review, CEA monitoring, CT and colonoscopy, with PET used when something needs resolving.
I have a stoma. Does that affect the scan?
It does not prevent it. Tell the centre at booking so preparation and positioning can be planned in advance rather than managed on arrival.
Why should I bring my old CEA results?
Because the trend matters more than any single value. A sequence showing the direction and rate of change gives the reporting physician useful context that one number cannot.
What does a colorectal PET CT cost?
Colorectal cancer studies are usually FDG whole body, which is Rs 7,999 all-inclusive of scan, tracer and reporting; FDG whole body with triple phase is Rs 13,499. Contrast or additional views can change the figure. Send the prescription on WhatsApp and we will share the all-inclusive figure for your exact study before you book.
Do I need a prescription?
Yes. A valid prescription is required for all PET CT studies, and it should state the clinical indication.
Related reading
- Triple phase PET CT explained — the liver protocol used before metastasectomy
- PET CT for pancreatic cancer — where FDG struggles and FAPI does better
- PET CT for oesophageal cancer — staging before major surgery
- PET CT scan price in Delhi — what decides your figure, and the nine questions to ask
Booking your scan
Send a photograph of the prescription to 8368225620 on WhatsApp. Include four things: the date of your last chemotherapy cycle, the date of any recent surgery or colonoscopy, whether you have a stoma, and your recent CEA results if the scan was prompted by a rise.
You will get the all-inclusive rate, a slot planned around the right interval, the written preparation instructions, and a note on which previous imaging and reports to carry.
Prefer to speak to someone? Call 8368225620 or 7011968879, Monday to Saturday, 8:00 AM to 5:00 PM.
This page is general information about the role of PET CT in colorectal cancer. It is not medical advice and must not be used to interpret your own report or CEA results, or to decide for or against a scan or an operation. Staging and treatment decisions are made by your treating team, who read the scan alongside your history, examination, pathology and other imaging. A valid prescription is required for all PET CT studies.